myriamed GmbH
- CMO, CRO
myriamed is at the forefront of humanizing drug development. Our IP owned, disease-specific and tissue-based 2D and 3D models from iPSCs will lead to replace animal testing and to accelerate drug development.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}